Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-02-12 @ 11:41 PM
Study NCT ID:
NCT05308966
Status:
COMPLETED
Last Update Posted:
2025-10-06
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
Sponsor:
Groupe Francais De Pneumo-Cancerologie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-03
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-17
First Submit QC Date:
None
Study First Post Date:
2022-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-01
Last Update Post Date:
2025-10-06
Last Update Post Date Type:
ESTIMATED